HRP20170793T1 - Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike - Google Patents

Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike Download PDF

Info

Publication number
HRP20170793T1
HRP20170793T1 HRP20170793TT HRP20170793T HRP20170793T1 HR P20170793 T1 HRP20170793 T1 HR P20170793T1 HR P20170793T T HRP20170793T T HR P20170793TT HR P20170793 T HRP20170793 T HR P20170793T HR P20170793 T1 HRP20170793 T1 HR P20170793T1
Authority
HR
Croatia
Prior art keywords
drug
combined
vaginal
cox1
nsaid
Prior art date
Application number
HRP20170793TT
Other languages
English (en)
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Marion Noe-Letschnig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Noe, Marion Noe-Letschnig filed Critical Christian Noe
Publication of HRP20170793T1 publication Critical patent/HRP20170793T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

1. Kombinirani lijek, naznačen time, da obuhvaća sljedeće: - antimikotičko sredstvo, pri čemu je navedeno antimikotičko sredstvo klotrimazol ili mikonazol, i - nesteroidni protuupalni lijek (NSAID) koji ima dovoljno COX1-inhibicije, definiran putem izdvajanja spojeva koji imaju omjer COX1/COX2 (IC50, microM) veći od 20, pri čemu navedeni NSAID je diklofenak ili mefenaminska kiselina, dok je lijek za uporabu u topikalnom liječenju Candida-mikoza koje su odabrane od sljedećih: vulvovaginalne kandidaze, orofaringealne kandidaze (afte u usnoj šupljini), pelenski dermatitis (pelenski osip), intertriginozni ekcem, pri čemu se navedeni kombinirani lijek pripravlja kao mast, krema, vaginalni supozitorij, vaginalna tableta, oralna tableta ili tableta za pod jezik, prašak ili aerosol.
2. Kombinirani lijek za uporabu prema zahtjevu 1, naznačen time, da se navedeni kombinirani lijek dostavlja na inertnom nosaču, posebno na vaginalnom prstenu, na dijafragmi ili na tamponu.
HRP20170793TT 2006-05-12 2017-05-26 Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike HRP20170793T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12
EP07718439.8A EP2018164B1 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika
PCT/AT2007/000227 WO2007131253A2 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika

Publications (1)

Publication Number Publication Date
HRP20170793T1 true HRP20170793T1 (hr) 2017-10-06

Family

ID=37903545

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170793TT HRP20170793T1 (hr) 2006-05-12 2017-05-26 Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike

Country Status (19)

Country Link
US (2) US8552042B2 (hr)
EP (2) EP3192507B1 (hr)
JP (1) JP2009536926A (hr)
CN (1) CN101484162A (hr)
AU (1) AU2007250502B2 (hr)
CA (1) CA2651726C (hr)
CY (1) CY1119094T1 (hr)
DK (1) DK2018164T3 (hr)
ES (1) ES2627268T3 (hr)
HR (1) HRP20170793T1 (hr)
HU (1) HUE033499T2 (hr)
LT (1) LT2018164T (hr)
NO (2) NO342103B1 (hr)
PL (1) PL2018164T3 (hr)
PT (1) PT2018164T (hr)
RS (1) RS56044B1 (hr)
RU (1) RU2008148977A (hr)
SI (1) SI2018164T1 (hr)
WO (1) WO2007131253A2 (hr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
CN107106690B (zh) 2015-01-13 2020-11-10 方济各安吉利克化学联合股份有限公司 用于治疗真菌病的药物组合物
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
MX2020005056A (es) * 2017-11-14 2020-10-28 Profem Gmbh Emulsiones para el tratamiento tópico de infecciones dérmicas y de mucosas.
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
WO2023220224A1 (en) * 2022-05-12 2023-11-16 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method
WO2024187210A1 (de) 2023-03-15 2024-09-19 Profem Gmbh Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
CA2177683C (en) * 1993-12-23 1999-12-28 George Endel Deckner Tissue moisturizing and antimicrobial compositions
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
WO2000048633A1 (en) 1999-02-19 2000-08-24 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
ATE375801T1 (de) 1999-03-24 2007-11-15 Zengen Inc Antimikrobielle aminosäuresequenzen aus alpha- melanocyten-stimulierendem hormon
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
WO2004060283A2 (en) * 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
US20070099932A1 (en) * 2003-06-25 2007-05-03 Toshihiro Shirouzu External preparation for athlete's foot treatment
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
AR049063A1 (es) * 2004-05-28 2006-06-21 Schering Corp Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas

Also Published As

Publication number Publication date
NO345064B1 (no) 2020-09-14
NO20180083A1 (no) 2009-02-10
WO2007131253A2 (de) 2007-11-22
EP2018164B1 (de) 2017-03-01
CA2651726C (en) 2015-12-15
WO2007131253A3 (de) 2008-11-27
EP3192507A1 (de) 2017-07-19
HUE033499T2 (en) 2017-12-28
DK2018164T3 (en) 2017-06-12
CY1119094T1 (el) 2018-01-10
EP2018164A2 (de) 2009-01-28
RU2008148977A (ru) 2010-06-20
RS56044B1 (sr) 2017-09-29
US20090208558A1 (en) 2009-08-20
PL2018164T3 (pl) 2017-08-31
JP2009536926A (ja) 2009-10-22
AU2007250502A1 (en) 2007-11-22
LT2018164T (lt) 2017-07-10
US20140030312A1 (en) 2014-01-30
SI2018164T1 (sl) 2017-07-31
US8815925B2 (en) 2014-08-26
NO342103B1 (no) 2018-03-26
US8552042B2 (en) 2013-10-08
ES2627268T3 (es) 2017-07-27
AU2007250502B2 (en) 2013-11-28
PT2018164T (pt) 2017-06-12
EP3192507B1 (de) 2020-07-08
CN101484162A (zh) 2009-07-15
CA2651726A1 (en) 2007-11-22
NO20085181L (no) 2009-02-10

Similar Documents

Publication Publication Date Title
HRP20170793T1 (hr) Uporaba kombiniranih pripravaka koji obuhvaćaju antimikotike
ATE541572T1 (de) Tetrahydro-naphtalinderviate als glucocorticoidrezeptor-modulatoren
WO2008065316A3 (fr) Compositions sous forme d'onguent comprenant un derive de vitamine d
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
MA33373B1 (fr) Composition pharmaceutique pour contraception d'urgence
FR2906140B1 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
CO6220926A2 (es) Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid)
WO2008057420A3 (en) Extended triterpene derivatives
MX351232B (es) Inhibidor de dpp-iv combinado con otro agente antidiabetico, tabletas que comprenden tales formulaciones, su uso y procedimiento para su preparacion.
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
AU2003247616A1 (en) Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
RS53209B (en) PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
UY29193A1 (es) Nuevas formulaciones de tabletas de liberación modificada para inhibidores de bomba de protón
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
NO20084328L (no) Nye forbindelser
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
WO2007014124A3 (en) High drug load formulations and dosage forms
JP2009502805A5 (hr)
WO2008012338A3 (en) Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
WO2008074834A3 (en) Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
WO2010039529A3 (en) Compositions and methods for the treament of inflammatory disease
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
WO2008074832A3 (en) Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)